JenThera Therapeutics

Jenthera develops novel CRISPR therapeutics using its proprietary precision gene editing platform allowing for the performance of advanced full spectrum gene editing. Unlocking an unprecedented array of possibilities for the tackling of genetic diseases, our technology aims at the development of groundbreaking therapeutics in oncology, cardiovascular indications, cell therapies and for broader polygenic gene editing. For more information visit: www.jenthera.com.